Top 3D Printing companies in Australia by Free Cash Flow Yield
Australia
# |
Name |
Free Cash Flow Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
7.24% |
Feb. 5, 2025 | USD 0.74 | 0.62% |
|
Australia |
|
| 2 |
3.99% |
Feb. 5, 2025 | USD 1.90 | 0.29% |
|
Australia |
|
| 3 |
2.60% |
Feb. 5, 2025 | USD 5.16 | 1.74% |
|
Australia |
|
| 4 |
1.92% |
Feb. 5, 2025 | USD 10.31 | 2.62% |
|
Australia |
|
| 5 |
1.54% |
Feb. 5, 2025 | USD 195.76 | 0.28% |
|
Australia |
|
| 6 |
0.28% |
Feb. 5, 2025 | USD 181.62 | 2.38% |
|
Australia |
|
| 7 |
0.15% |
Feb. 5, 2025 | USD 18.33 | -0.84% |
|
Australia |
|
| 8 |
0.06% |
Feb. 5, 2025 | USD 1.23 | -0.40% |
|
Australia |
|
| 9 |
-2.08% |
Feb. 5, 2025 | USD 1.90 | -4.74% |
|
Australia |
|
| 10 |
-3.29% |
Feb. 5, 2025 | USD 1.45 | -3.95% |
|
Australia |
|
| 11 |
-3.81% |
Feb. 5, 2025 | USD 2.46 | 10.79% |
|
Australia |
|
| 12 |
-16.38% |
Feb. 5, 2025 | USD 6.16 | 2.82% |
|
Australia |
Frequently Asked Questions
-
Which 3D Printing company in Australia has the highest Free Cash Flow Yield ?
The 3D Printing company in Australia with the highest Free Cash Flow Yield is Monash IVF Group Limited (ASX: MVF.AX) at 7.24%.
-
Which 3D Printing company in Australia has the lowest Free Cash Flow Yield ?
The 3D Printing company in Australia with the lowest Free Cash Flow Yield is Anteris Technologies Ltd (ASX: AVR.AX) at -16.38%.
-
What are the top 10 3D Printing companies in Australia by Free Cash Flow Yield ?
The top 10 3D Printing companies in Australia by Free Cash Flow Yield are Monash IVF Group Limited, Integral Diagnostics Limited, PWR Holdings Limited, Codan Limited, Cochlear Limited, Pro Medicus Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Mesoblast Limited and Cyclopharm Limited.
-
What are the bottom 10 3D Printing companies in Australia by Free Cash Flow Yield ?
The bottom 10 3D Printing companies in Australia by Free Cash Flow Yield are Anteris Technologies Ltd, Clarity Pharmaceuticals Ltd, Cyclopharm Limited, Mesoblast Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, Pro Medicus Limited, Cochlear Limited, Codan Limited and PWR Holdings Limited.
